Trademark: 87062150
Word
ASPIRA IVD
Status
Dead
Status Code
710
Status Date
Friday, August 30, 2024
Serial Number
87062150
Registration Number
5408258
Registration Date
Tuesday, February 20, 2018
Mark Type
4
Filing Date
Monday, June 6, 2016
Published for Opposition
Tuesday, May 16, 2017
Cancellation Date
Friday, August 30, 2024

Trademark Owner History

Classifications
44 Diagnostic testing and clinical research services for clinical trials and research studies in the field of oncology, gynecology and women's health
"IVD"

Trademark Events
Sep 20, 2016
Notification Of Non-Final Action E-Mailed
Jun 9, 2016
New Application Entered
Jun 14, 2016
New Application Office Supplied Data Entered
Sep 16, 2016
Assigned To Examiner
Sep 20, 2016
Non-Final Action Written
Sep 20, 2016
Non-Final Action E-Mailed
Oct 17, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 17, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 6, 2016
Assigned To Examiner
Mar 16, 2017
Teas Response To Office Action Received
Mar 16, 2017
Correspondence Received In Law Office
Mar 17, 2017
Teas/Email Correspondence Entered
May 16, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 3, 2017
Approved For Pub - Principal Register
Apr 26, 2017
Notification Of Notice Of Publication E-Mailed
May 16, 2017
Published For Opposition
Jan 16, 2018
Allowed Principal Register - Sou Accepted
Jul 11, 2017
Noa E-Mailed - Sou Required From Applicant
Jan 9, 2018
Teas Statement Of Use Received
Jan 9, 2018
Sou Teas Extension Received
Jan 9, 2018
Sou Extension 1 Filed
Jan 14, 2018
Case Assigned To Intent To Use Paralegal
Jan 9, 2018
Use Amendment Filed
Jan 14, 2018
Sou Extension 1 Granted
Jan 14, 2018
Statement Of Use Processing Complete
Jan 16, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 20, 2018
Registered-Principal Register
Feb 20, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 30, 2024
Cancelled Sec. 8 (6-Yr)
Aug 12, 2020
Automatic Update Of Assignment Of Ownership

Trademark Alertz updated from USPTO on 2030-01-24